Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Bio    DIM   FR0000053266

Delayed Quote. Delayed  - 04/29 05:35:30 pm
333.5 EUR   -0.19%
04/13 SARTORIUS STEDI : ex-dividend day for annual dividend
03/02 SARTORIUS STEDI : utsource Contract Testing Facility in Glasgow Succ..
01/20 SARTORIUS STEDI : ech presents new crossflow filtration system for p..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201320142015201620172018
Sales5886848841 0141 1001 230
Operating income (EBITDA)136161231277302347
Operating profit (EBIT)-120-228255314
Pre-Tax Profit (EBT)-105170211241-
Net income67,572,5139150172211
P/E ratio24,934,239,036,331,5-
EPS ( € )4,904,729,069,1910,6-
Dividend per Share ( € )1,201,30-1,942,292,10
Yield0,98%0,81%-0,58%0,69%0,63%
Reference price ( € )121.85161.3353.4333.5333.5333.5
Announcement Date01/28/2014
06:00am
01/27/2015
04:00pm
02/01/2016
06:00am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201320142015201620172018
Debt-87,486,4--224
Finance---14,529,1-
Operating income (EBITDA)136161231277302347
Leverage
(Debt/EBITDA)
-0,54x0,37x--0,65x
Capital Expenditure29,347,153,069,777,086,0
Book Value Per Share (BVPS)-34,7 €41,7 €49,8 €47,2 €71,4 €
Cash Flow per Share-7,25 €-12,3 €14,0 €16,0 €
Announcement Date01/28/2014
06:00am
01/27/2015
04:00pm
02/01/2016
06:00am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 5 671 M€ -
Entreprise Value (EV) 5 657 M€ 5 642 M€
Valuation 2016e 2017e
P/E ratio (Price / EPS) 36,3x 31,5x
Capitalization / Revenue 5,59x 5,16x
EV / Revenue 5,58x 5,13x
EV / EBITDA 20,4x 18,7x
Yield (DPS / Price) 0,58% 0,69%
Price to book (Price / BVPS) 6,69x 7,06x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 22,5% 23,2%
operating Leverage (Delta EBIT / Delta Sales) - 1,38x
Net Margin (Net Profit / Revenue) 14,8% 15,6%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 20,6% 20,2%
Rate of Dividend 21,1% 21,6%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   6,87% 7,00%
Cash Flow / Sales 18,7% 19,6%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) -0,05x -0,10x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend